New Analysis of Food and Drug Administration Oncology Drug Approvals

被引：0
|
作者：
Lang, Les
机构：
来源：
GASTROENTEROLOGY | 2010年 / 138卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1639 / 1640
页数：3
相关论文
共 50 条
  • [31] Food and Drug Administration approvals in phase 3 Cancer clinical trials
    Joseph Abi Jaoude
    Ramez Kouzy
    Marc Ghabach
    Roshal Patel
    Dario Pasalic
    Elie Ghossain
    Austin B. Miller
    Timothy A. Lin
    Vivek Verma
    C. David Fuller
    Vivek Subbiah
    Bruce D. Minsky
    Ethan B. Ludmir
    Cullen M. Taniguchi
    BMC Cancer, 21
  • [32] Food and Drug Administration approvals in phase 3 Cancer clinical trials
    Jaoude, Joseph Abi
    Kouzy, Ramez
    Ghabach, Marc
    Patel, Roshal
    Pasalic, Dario
    Ghossain, Elie
    Miller, Austin B.
    Lin, Timothy A.
    Verma, Vivek
    Fuller, C. David
    Subbiah, Vivek
    Minsky, Bruce D.
    Ludmir, Ethan B.
    Taniguchi, Cullen M.
    BMC CANCER, 2021, 21 (01)
  • [33] Vascular Surgery Innovation Over Three Decades: An Analysis of Food and Drug Administration Device Approvals
    Wiske, Clay
    Barfield, Michael E.
    Suh, Insoo
    Schneider, Peter A.
    Maldonado, Thomas S.
    JOURNAL OF VASCULAR SURGERY, 2023, 77 (06) : E169 - E169
  • [34] US Food and Drug Administration Recommendations on the Use of Surrogate Measures as End Points in New Anti-infective Drug Approvals
    Hey, Spencer Phillips
    Kesselheim, Aaron S.
    Patel, Pranav
    Mehrotra, Preeti
    Powers, John H., III
    JAMA INTERNAL MEDICINE, 2020, 180 (01) : 131 - 138
  • [35] Assessing drug lag in new drug approvals by the Iran Food and Drug Administration compared to the US FDA, EMA, and PMDA: A 20-year analysis (2001-2021)
    Alipour, Sama
    Parashkouhi, Sadra Nadimi
    Mojahedian, Mohammadmahdi
    Abbasian, Hadi
    MEDICINE, 2024, 103 (25)
  • [36] Accelerated drug approvals in oncology: Pros and cons
    Thakur, Sayanta
    Lahiry, Sandeep
    INDIAN JOURNAL OF CANCER, 2021, 58 (01) : 114 - 118
  • [37] Core limitations in clinical trials leading to anticancer drug approvals by the US Food and Drug Administration.
    Hilal, Talal
    Gonzalez-Velez, Miguel
    Prasad, Vinay
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] US FDA oncology drug approvals in 2014
    Wolford, Juliet E.
    Tewari, Krishnansu S.
    FUTURE ONCOLOGY, 2015, 11 (13) : 1931 - 1945
  • [39] Characteristics and outcomes of new molecular oncology drug approvals, in combination or monotherapy
    Ranganathan, Sruthi
    Haslam, Alyson
    Tuia, Jordan
    Prasad, Vinay
    JOURNAL OF CANCER POLICY, 2024, 39
  • [40] USE OF EXTERNAL CONTROL ARMS IN NOVEL DRUG APPROVALS BY US FOOD AND DRUG ADMINISTRATION: A TARGETED REVIEW
    Gupta, P.
    Kumar, J.
    Shaikh, J.
    VALUE IN HEALTH, 2024, 27 (06) : S204 - S204
12345